---
title: monoclonal gammopathy of uncertain significance (MGUS)
alias: MGUS
date: "2023-01-22"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[plasma cell dyscrasias]]

# monoclonal gammopathy of uncertain significance (MGUS)

- Premalignancy w/ clonal plasma cell (PC) proliferation.
- No e/o other B-cell disease.
- <10% monoclonal PCs in BM,
- <3 g/dL serum M-protein,
- & no MM-related organ dysfunction s/s

## monoclonal gammopathy of uncertain significance (MGUS)

(NEJM 2018;378:241)

- âœ“ CBC, Ca, Cr, SPEP, serum free light chains, UPEP w/ immunofixation (to exclude MM)
- Close observation: repeat SPEP in 6 mo, then â†’ yearly thereafter if stable
- ~1%/y or ~25% lifetime risk â†’ MM, WM, amyloidosis, or malign. lymphoproliferative dis.
- Abnormal serum free light chain ratio & M protein â‰¥1.5 g/dL: â†‘ risk of progression to MM

## [[Smoldering Multiple Myeloma]]

- Need whole-body MRI or PET-CT to rule out occult bone lesions
- Risk of prog. 10%/y, depends on [M protein], subtype, FLC ratio. No defined role for Rx yet though trials ongoing (NEJM 2013;369:438; Blood 2019;134:781; JCO 2020;38:1126).
